lifastuzumab vedotin

Ligand id: 8405

Name: lifastuzumab vedotin

References
1. Dennis M, Rubinfeld B, Polakis P. (2013)
Compositions and methods for the diagnosis and treatment of tumor.
Patent number: US8535675 B2. Assignee: Genentech, Inc.. Priority date: 30/11/2009. Publication date: 17/09/2013.